(Q27006030)

Yang Yang

series ordinal

2

1 reference

language of work or name

1 reference

2013

1 reference

Clinical and Developmental Immunology

8 October 2013

1 reference

28 October 2022

2 references

28 October 2022

2013

1 reference

page(s)

859761

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

1 reference

Europe PubMed Central

Proteasome inhibitor-based therapy for antibody-mediated rejection

28 October 2022

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Incidence and impact of de novo donor-specific alloantibody in primary renal allografts

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Pathology of C4d-negative antibody-mediated rejection in renal allografts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Antibody-mediated vascular rejection of kidney allografts: a population-based study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Antibody-Mediated Lung Transplant Rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Prevention of antibody-mediated kidney transplant rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Antibody-mediated rejection in the liver allograft

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Antibody-mediated rejection after intestinal transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Diagnosis and prevention of chronic kidney allograft loss

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

The pathogenesis and treatment of chronic allograft nephropathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Banff 07 classification of renal allograft pathology: updates and future directions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Transplant glomerulopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Antibody-mediated organ-allograft rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Chronic renal allograft dysfunction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Kidney transplants, antibodies and rejection: is C4d a magic marker?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

National conference to assess antibody-mediated rejection in solid organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Endothelial injury in transplant glomerulopathy is correlated with transcription factor T-bet expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

The pathogenesis of acute allograft dysfunction in desensitized renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

A survey of current practice for antibody-mediated rejection in heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F859761

Early versus late acute antibody-mediated rejection in renal transplant recipients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816029

Antibody-mediated rejection--an ounce of prevention is worth a pound of cure

28 November 2018

1 reference

12 December 2020

Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil

1 reference

12 December 2020

Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant

1 reference

12 December 2020

Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema

1 reference

12 December 2020

All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies

1 reference

12 December 2020

Microcirculation lesions alone are not reliable for identifying antibody-mediated rejection

1 reference

12 December 2020

Rituximab therapy for acute humoral rejection after kidney transplantation

1 reference

12 December 2020

Successful rescue of refractory, severe antibody mediated rejection with splenectomy

1 reference

12 December 2020

Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients

1 reference

12 December 2020

Complement C4d immunohistochemistry in the assessment of liver allograft biopsy samples: applications and pitfalls

1 reference

12 December 2020

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')

1 reference

12 December 2020

Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation

1 reference

12 December 2020

Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation

1 reference

12 December 2020

C4d immunostaining in acute humoral rejection after ABO blood group-incompatible liver transplantation

1 reference

12 December 2020

Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft

1 reference

12 December 2020

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence

1 reference

12 December 2020

Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/859761

1 reference

1943415

1943415

1 reference

1 reference

1 reference